(Q74050875)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Plasminogen activator inhibitor type 1 in adults with Down syndrome and protection against macrovascular disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

W E Hopkins

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

N K Fukagawa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

B E Sobel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

D J Schneider

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

784-6, A9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

Life expectancy in Down syndrome

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Down's syndrome: an atheroma-free model?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Down's syndrome and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

DOES DOWN SYNDROME SUPPORT HOMOCYSTEINE THEORY OF ARTERIOSCLEROSIS?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Plasma Concentration of Endogenous Tissue Plasminogen Activator and the Occurrence of Future Cardiovascular Events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Increased incidence and prevalence of diabetes mellitus in Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

Lipids and lipoproteins in persons with Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900864-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(99)00864-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12000063%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference